1977
DOI: 10.1001/archpsyc.1977.01770180035002
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Dopamine Synthesis in Chronic Schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
11
0

Year Published

1979
1979
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(11 citation statements)
references
References 40 publications
0
11
0
Order By: Relevance
“…1968; Jonsson et a1. 1971;Ahlenius et al 1973; 0893-133X/93/$0 .00 Pozuelo 1976;Nasrallah et al 1977}. In addition, it has been noted that discontinuation of AMPT treatment is associated with insomnia and decreased total sleep (Bunney et al 1971(Bunney et al , 1977.…”
mentioning
confidence: 99%
“…1968; Jonsson et a1. 1971;Ahlenius et al 1973; 0893-133X/93/$0 .00 Pozuelo 1976;Nasrallah et al 1977}. In addition, it has been noted that discontinuation of AMPT treatment is associated with insomnia and decreased total sleep (Bunney et al 1971(Bunney et al , 1977.…”
mentioning
confidence: 99%
“…Therefore, research on the treatment of gastric I/R injury is ongoing. Metyrosine, the protective effect of which against gastric I/R injury we will try in this study, is an inhibitor of the tyrosine enzyme that participates in the synthesis of catecholamine 10 . There are studies reporting the antioxidant activity of metyrosine 11 .…”
Section: ■ Introductionmentioning
confidence: 99%
“…Carlsson's group reported that AMPT treatment allowed a 60-to 79-percent mean reduction in the neuroleptic dose required to control psychotic symptoms in eight chronic schizophrenics (Carlsson et al 1972b(Carlsson et al , 1973Walinder et al 1976). This finding was replicated by Magelund, Gerlach, and Casey (1979), but not by Nasrallah et al (1977) and Gillin et al (1979). Magelund, Gerlach, andCasey (1979) studied 12 chronic schizophrenics whose psychotic symptoms had been exacerbated by a 67-percent mean reduction in their neuroleptic dosage.…”
Section: Clinical Effects Of Drugs That Alter Dopaminergic Activitymentioning
confidence: 84%